+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Novo Nordisk A/S - logo

Novo Nordisk is a global healthcare company with more than 90 years of innovation and leadership in diabetes care. Key products include diabetes care medications and devices. Novo Nordisk is also involved with hemostasis management, growth hormone therapy and hormone replacement therapy. Headquartered in Denmark, Novo Nordisk employs approximately 40,000 employees in 75 countries, and markets its products in more than 180 countries.

Peptide Synthesis Market - Global Forecast 2026-2032 - Product Thumbnail Image

Peptide Synthesis Market - Global Forecast 2026-2032

  • Report
  • January 2026
  • 188 Pages
  • Global
From
Obesity: Competitive Landscape to 2026 - Product Thumbnail Image

Obesity: Competitive Landscape to 2026

  • Report
  • October 2018
  • 50 Pages
  • Global
From
From
From
Glucagon-like Peptide 1 Market Report 2026 - Product Thumbnail Image

Glucagon-like Peptide 1 Market Report 2026

  • Report
  • January 2026
  • 250 Pages
  • Global
From
From
Hemophilia Drugs - Global Strategic Business Report - Product Thumbnail Image

Hemophilia Drugs - Global Strategic Business Report

  • Report
  • February 2026
  • 182 Pages
  • Global
From
Bleeding Disorder Drugs Market - Global Strategic Business Report - Product Thumbnail Image

Bleeding Disorder Drugs Market - Global Strategic Business Report

  • Report
  • February 2026
  • 488 Pages
  • Global
From
Sickle-Cell Anemia Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Sickle-Cell Anemia Therapeutics - Global Strategic Business Report

  • Report
  • February 2026
  • 181 Pages
  • Global
From
Loading Indicator